The Oncosearch | Oncotarget

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Neelam Shirsat, Sridhar Epari, Girish Chinnaswamy, Tejpal Gupta

Published Feb 2, 2023 · Vol. 14, No. 1 · pp. 105-110

Keywords: de-intensification, medulloblastoma, molecular, survival, toxicity

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima

Published Jan 25, 2023 · Vol. 14, No. 1 · pp. 71-82

Keywords: gastric cancer, laparoscopic gastrectomy, novel predictive index, inflammation-combined prognostic index, cancer-specific survival

The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option Research Paper

Jessica T. Gomes, Ana Márcia V. Wanzeler, Sergio M.A. Júnior, Rosa Helena F. Chaves Soares, Carolina P. de Oliveira, Emanuelle de M. Rodrigues, Bruno M. Soares, Diego D.F.A. Alcantara, Rommel M.R. Burbano, Fabrício M. Tuji

Published Dec 22, 2022 · Vol. 14, No. 1 · pp. 23-39

Keywords: phytotherapeutic drugs, medical oncology, stomatitis, wound healing, low-level light therapy

The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in Golden syrian hamsters: a new treatment option Research Paper

Jessica T. Gomes, Ana Márcia V. Wanzeler, Sergio M.A. Júnior, Rosa Helena F. Chaves Soares, Carolina P. de Oliveira, Emanuelle de M. Rodrigues, Bruno M. Soares, Diego D.F.A. Alcantara, Rommel M.R. Burbano, Fabrício M. Tuji

Published Dec 22, 2022

Keywords: phytotherapeutic drugs, medical oncology, stomatitis, wound healing, low-level light therapy

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Michèle Welti, Phil F. Cheng, Joanna Mangana, Mitchell P. Levesque, Reinhard Dummer, Laurence Imhof

Published Dec 14, 2022 · Vol. 13, No. 1 · pp. 1370-1379

Keywords: metastatic melanoma, Covid-19, Sars-CoV-2, immunotherapy, targeted therapy

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022 · Vol. 13, No. 1 · pp. 1341-1349

Keywords: microRNA, early palliative care, integration, cancer, referral

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022

Keywords: microRNA, early palliative care, integration, cancer, referral

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma Addendum

Yongshun Chen, Xiaoyuan Wu, Daxuan Hao, Xinyu Cheng, Lei Zhang, Yougai Zhang, Shaobo Ke, Wei Shi, Chunyu He

Published Nov 23, 2022 · Vol. 13, No. 1 · pp. 1300-1300

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Daniel J. Landsburg, Jennifer J.D. Morrissette, Stephen J. Schuster, Sunita D. Nasta, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Megan S. Lim

Published Nov 5, 2022 · Vol. 13, No. 1 · pp. 1237-1244

Keywords: diffuse large B cell lymphoma, high grade B cell lymphoma, mutation analysis, next generation sequencing, chemotherapy

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Neal Murphy, Andrew J. Shih, Paras Shah, Oksana Yaskiv, Houman Khalili, Anthony Liew, Annette T. Lee, Xin-Hua Zhu

Published Oct 20, 2022 · Vol. 13, No. 1 · pp. 1188-1200

Keywords: muscle invasive bladder cancer, neoadjuvant chemotherapy, gene expression, molecular subtyping, canonical correlation analysis

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

Michael Jonathan Kucharczyk, Andrew Bang, Michael C. Tjong, Stefania Papatheodorou, Jesus C. Fabregas

Published Sep 30, 2022 · Vol. 13, No. 1 · pp. 1109-1119

Keywords: radiotherapy, meta-analysis, systematic review, rectal cancer, total mesorectal excision

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

Liza A. Wijler, Francina J. Dijk, Hanil Quirindongo, Danielle A.E. Raats, Bram Dorresteijn, Matthew J.W. Furber, Anne M. May, Onno Kranenburg, Miriam van Dijk

Published Sep 27, 2022 · Vol. 13, No. 1 · pp. 1094-1108

Keywords: C2C12 myotubes, chemotherapy, chemotherapy-associated toxicity, colorectal cancer, nutrients, tumor (organoid) cells

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs Research Paper

Benigno C. Valdez, Yago Nieto, Bin Yuan, David Murray, Borje S. Andersson

Published Sep 24, 2022 · Vol. 13, No. 1 · pp. 1122-1135

Keywords: poly(ADP-ribosyl)ation, HDAC inhibitors, PARP inhibitors, chemotherapy, hematologic malignancy

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Melanie Demes, Ursula Pession, Jan Jeroch, Falko Schulze, Katrin Eichler, Daniel Martin, Peter Wild, Oliver Waidmann

Published Sep 8, 2022 · Vol. 13, No. 1 · pp. 1034-1042

Keywords: anal cancer, microsatellite instability, immunotherapy, high-throughput nucleotide sequencing, nivolumab

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy Research Paper

Daiki Ueno, Juan C. Vasquez, Amrita Sule, Jiayu Liang, Jinny van Doorn, Ranjini Sundaram, Sam Friedman, Randy Caliliw, Shinji Ohtake, Xun Bao, Jing Li, Huihui Ye, Karla Boyd, Rong Rong Huang, Jack Dodson, Paul Boutros, Ranjit S. Bindra, Brian Shuch

Published Sep 3, 2022 · Vol. 13, No. 1 · pp. 1054-1067

Keywords: FH, SDHB, renal cell carcinoma, PARP inhibitor, temozolomide

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Francis R. LeBlanc, Zainul S. Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Violetta V. Leshchenko, Samir Parekh, Haiqing Fu, Ya Zhang, Melvenia M. Martin, Mark Kester, Todd Fox, Jiangang Liao, Thomas P. Loughran, Juanita Evans, Jeffrey J. Pu, Stephen E. Spurgeon, Mirit I. Aladjem, Elliot M. Epner

Published Jul 9, 2022 · Vol. 13, No. 1 · pp. 986-1002

Keywords: epigenetics, blastic mantle cell lymphoma, cladribine

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Reyes Bernabé-Caro, Pilar Garrido, Rosario García-Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, Delvys Rodríguez-Abreu, Marta López-Brea, Alfredo Paredes, David Vicente, José Miguel Sánchez Torres, Margarita Majem, Pilar Diz, Rocío Gordo, Margarita Coca, Javier de Castro

Published Jun 7, 2022 · Vol. 13, No. 1 · pp. 812-827

Keywords: ALK-positive NSCLC, ALK inhibitor, crizotinib, alectinib, unselected patient

Targeting lipid metabolism in the treatment of ovarian cancer Review

Saliha Chaudhry, Stefani N. Thomas, Glenn E. Simmons Jr.

Published May 18, 2022 · Vol. 13, No. 1 · pp. 768-783

Keywords: ovarian cancer, lipid metabolism, biomarkers, microenvironment, fatty acid

Correction: Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy Correction

Wen Yu, De-Dong Cao, Qiu-bai Li, Hui-ling Mei, Yu Hu, Tao Guo

Published May 11, 2022 · Vol. 14, No. 1 · pp. 821-823

HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer Research Paper

Naokazu Chiba, Shigeto Ochiai, Takahiro Gunji, Toshimichi Kobayashi, Toru Sano, Koichi Tomita, Shigeyuki Kawachi

Published May 11, 2022 · Vol. 13, No. 1 · pp. 747-754

Keywords: HOXB9, pancreatic cancer, epithelial mesenchymal transition, TGFβ

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option Research Paper

The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in Golden syrian hamsters: a new treatment option Research Paper

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma Addendum

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs Research Paper

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Targeting lipid metabolism in the treatment of ovarian cancer Review

Correction: Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy Correction

HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option Research Paper

The chromatographic constitution of andiroba oil and his healing effects, compared to the LLLT outcomes, in oral mucositis induced in Golden syrian hamsters: a new treatment option Research Paper

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma Addendum

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs Research Paper

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Targeting lipid metabolism in the treatment of ovarian cancer Review

Correction: Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy Correction

HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer Research Paper